APA (7th ed.) Citation

OA, S., G, J., M, S., J, Z., S, D., SS, C., . . . JS, M. (2025). EVOLVE platform, a trispecific T cell engager with integrated CD2 costimulation, for the treatment of solid and hematologic tumors. Proceedings of the National Academy of Sciences of the United States of America, 122(47), e2510829122. https://doi.org/10.1073/pnas.2510829122

Chicago Style (17th ed.) Citation

OA, Sergeeva, et al. "EVOLVE Platform, a Trispecific T Cell Engager with Integrated CD2 Costimulation, for the Treatment of Solid and Hematologic Tumors." Proceedings of the National Academy of Sciences of the United States of America 122, no. 47 (2025): e2510829122. https://doi.org/10.1073/pnas.2510829122.

MLA (9th ed.) Citation

OA, Sergeeva, et al. "EVOLVE Platform, a Trispecific T Cell Engager with Integrated CD2 Costimulation, for the Treatment of Solid and Hematologic Tumors." Proceedings of the National Academy of Sciences of the United States of America, vol. 122, no. 47, 2025, p. e2510829122, https://doi.org/10.1073/pnas.2510829122.